[1] |
World Health Organization.Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
|
[2] |
Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med, 2011, 364(15):1441-1448. doi:10.1056/NEJMcp1005750.
|
[3] |
National Tuberculosis Controllers Association, Centers for Disease Control and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep, 2005, 54(RR-15):1-47.
|
[4] |
Reichler MR, Reves R, Bur S, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA, 2002, 287(8):991-995. doi:10.1001/jama.287.8.991.
|
[5] |
Krishnamoorthy Y, Ezhumalai K, Murali S, et al. Prevalence and risk factors associated with latent tuberculosis infection among household contacts of smear positive pulmonary tuberculosis patients in South India. Trop Med Int Health, 2021, 26(12):1645-1651. doi:10.1111/tmi.13693.
URL
pmid: 34654061
|
[6] |
Stagg HR, Zenner D, Harris RJ, et al. Treatment of latent tuberculosis infection: a network meta-analysis. Ann Intern Med, 2014, 161(6):419-428. doi:10.7326/M14-1019.
URL
pmid: 25111745
|
[7] |
World Health Organization. WHO steps up the Director-General’s flagship initiative to combat tuberculosis[EB/OL]. [2023-03-23].https://www.who.int/news/item/23-03-2023-who-steps-up-the-director-general-s-flagship-initiative-to-combat-tuberculosis.
|
[8] |
中华人民共和国国家卫生和计划生育委员会.WS 288—2017肺结核诊断. 2017-11-09.
|
[9] |
徐彩红, 赵雁林. 中国结核病预防性治疗指南. 北京: 人民卫生出版社, 2023:17-21.
|
[10] |
玛依沙·达肯, 陈阳贵, 李德洋, 等. 2021—2022年乌鲁木齐市肺结核家庭密切接触者预防性治疗意愿的影响因素分析. 预防医学情报杂志, 2023, 39(8):918-925.
|
[11] |
马志. 新疆伊宁市初高中及大中专院校新生结核潜伏感染状况及随访研究. 乌鲁木齐:新疆医科大学, 2022. doi:10.27433/d.cnki.gxyku.2022.000508.
|
[12] |
任哲雯, 张国龙, 龚德华, 等. 结核潜伏感染者对12周预防性治疗方案的接受意愿研究. 中国防痨杂志, 2020, 42(5):503-509. doi:10.3969/j.issn.1000-6621.2020.05.016.
|
[13] |
李果, 徐华, 敬明燕, 等. 某县结核潜伏感染者拒绝预防性治疗的原因分析和对策评价. 临床肺科杂志, 2022, 27(9):1415-1420. doi:10.3969/j.issn.1009-6663.2022.09.025.
|
[14] |
尤媛媛, 张国龙, 陈裕. 120例初治耐多药肺结核患者治疗依从性的影响因素分析. 中国防痨杂志, 2020, 42(3):249-254. doi:10.3969/j.issn.1000-6621.2020.03.013.
|
[15] |
李珍, 常立阳, 王玲华. 肺结核患者健康教育在临床实践中的实施现状与思考. 中国防痨杂志, 2021, 43(11):1132-1138. doi:10.3969/j.issn.1000-6621.2021.11.006.
|
[16] |
李秋燕, 曹秀玲, 赵广通, 等. 山东省肺结核患者疾病经济负担及影响因素分析. 中国卫生经济, 2010, 29(4): 71-73. doi:10.3969/j.issn.1003-0743.2010.04.025.
|
[17] |
Aung ST, Thu A, Aung HL, et al. Measuring Catastrophic Costs Due to Tuberculosis in Myanmar. Trop Med Infect Dis, 2021, 6(3):130. doi:10.3390/tropicalmed6030130.
|
[18] |
王春雷, 金韬, 赵鹏鹏, 等. 江苏省淮安市耐多药肺结核患者服药依从性及影响因素分析. 中国防痨杂志, 2022, 44(10):1057-1062. doi:10.19982/j.issn.1000-6621.20220214.
|
[19] |
夏愔愔, 詹思延. 国内抗结核药物不良反应发生率的综合分析. 中华结核和呼吸杂志, 2007, 30(6):419-423. doi:10.3760/j.issn:1001-0939.2007.06.007.
|
[20] |
余水兰. 中国肺结核患者治疗依从性及其影响因素. 应用预防医学, 2022, 28(4):405-408. doi:10.3969/j.issn.1673-758X.2022.04.030.
|
[21] |
马艳, 成诗明. 加速我国结核潜伏感染筛查与预防性治疗的建议. 实用医学杂志, 2023, 39(11):1335-1340. doi:10.3969/j.issn.1006-5725.2023.11.003.
|